de Haan L - Search Results

1

Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.

Modinos G, Kempton MJ, Tognin S, Calem M, Porffy L, Antoniades M, Mason A, Azis M, Allen P, Nelson B, McGorry P, Pantelis C, Riecher-Rössler A, Borgwardt S, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Glenthøj B, Ruhrmann S, Sachs G, Rutten B, van Os J, de Haan L, Velthorst E, van der Gaag M, Valmaggia LR, McGuire P; EU-GEI High Risk Study Group. Modinos G, et al. Among authors: de haan l. JAMA Psychiatry. 2020 Feb 1;77(2):190-200. doi: 10.1001/jamapsychiatry.2019.3501. JAMA Psychiatry. 2020. PMID: 31722018 Free PMC article.

2

The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model.

van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, van Harten PN, Valmaggia L, de Hert M, Cuijpers A, Wiersma D. van der Gaag M, et al. Among authors: de haan l, de hert m. Schizophr Res. 2006 Jul;85(1-3):280-7. doi: 10.1016/j.schres.2006.03.021. Epub 2006 May 26. Schizophr Res. 2006. PMID: 16730429

3

The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions.

van der Gaag M, Cuijpers A, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, van Harten PN, Valmaggia L, de Hert M, Wiersma D. van der Gaag M, et al. Among authors: de haan l, de hert m. Schizophr Res. 2006 Jul;85(1-3):273-9. doi: 10.1016/j.schres.2006.04.001. Epub 2006 May 26. Schizophr Res. 2006. PMID: 16730430

4

Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.

Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, de Haan L, van Amelsvoort T, Linszen DH. Velthorst E, et al. Among authors: de haan l. Schizophr Res. 2009 Apr;109(1-3):60-5. doi: 10.1016/j.schres.2009.02.002. Epub 2009 Mar 9. Schizophr Res. 2009. PMID: 19272756

5

Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.

Nieman DH, Rike WH, Becker HE, Dingemans PM, van Amelsvoort TA, de Haan L, van der Gaag M, Denys DA, Linszen DH. Nieman DH, et al. Among authors: de haan l. Int Clin Psychopharmacol. 2009 Jul;24(4):223-8. doi: 10.1097/YIC.0b013e32832e0a76. Int Clin Psychopharmacol. 2009. PMID: 19521246 Free article.

6

White matter connectivity and psychosis in ultra-high-risk subjects: a diffusion tensor fiber tracking study.

Peters BD, Dingemans PM, Dekker N, Blaas J, Akkerman E, van Amelsvoort TA, Majoie CB, den Heeten GJ, Linszen DH, de Haan L. Peters BD, et al. Among authors: de haan l. Psychiatry Res. 2010 Jan 30;181(1):44-50. doi: 10.1016/j.pscychresns.2009.10.008. Psychiatry Res. 2010. PMID: 19954931

7

Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.

Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Korver N, et al. Among authors: de haan l. Aust N Z J Psychiatry. 2010 Mar;44(3):230-6. doi: 10.3109/00048670903487118. Aust N Z J Psychiatry. 2010. PMID: 20180725

8

Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.

Machielsen M, van der Sluis S, de Haan L. Machielsen M, et al. Among authors: de haan l. Aust N Z J Psychiatry. 2010 Aug;44(8):721-8. doi: 10.3109/00048671003689710. Aust N Z J Psychiatry. 2010. PMID: 20636193

9

Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms.

Boyette L, Swets M, Meijer C, Wouters L; GROUP Authors. Boyette L, et al. Psychiatry Res. 2011 Apr 30;186(2-3):409-13. doi: 10.1016/j.psychres.2010.07.048. Epub 2010 Aug 30. Psychiatry Res. 2011. PMID: 20800902 Free article.

10

Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls.

Derks EM, Allardyce J, Boks MP, Vermunt JK, Hijman R, Ophoff RA; GROUP. Derks EM, et al. Schizophr Bull. 2012 May;38(3):495-505. doi: 10.1093/schbul/sbq103. Epub 2010 Sep 23. Schizophr Bull. 2012. PMID: 20864620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters